Hantavirus in Africa: why climate change, rats and weak surveillance are worrying scientists
Wolfgang Preiser, Carla Mavian, Cheryl Baxter, Richard Lessells and Tulio de Oliveira
More news
Aspen Pharmacare to capitalise on GLP-1 demand in sub-Saharan Africa
Nqobile Dludla 4 Mar 2026
Novartis' new drug more than 97% effective at treating malaria
Jennifer Rigby 13 Nov 2025
Cholera in northwest Nigeria: Limited healthcare access leaves communities at risk
Ahmed Kingimi 28 Aug 2025
#BestofBiz 2020: Healthcare
14 Dec 2020
Why can't Africa manufacture the medicines it needs?
Janet Byaruhanga 28 Sep 2020
#BestofBiz 2019: Healthcare
17 Dec 2019
Using nanomedicine to fight TB
Nicklaus Kruger 6 Dec 2019
ARV breakthrough: trial in South Africa confirms effectiveness of new drug
Michelle Moorhouse & Willem Daniel Francois Venter 29 Nov 2019
Ebola one year on: the wins, the setbacks, and the way forward
Shirin Ashraf & Emma Thomson 30 Sep 2019
The three big studies pushing at the frontiers of HIV prevention
Glenda Gray 14 Jun 2019
What the US could learn about vaccination from Nigeria
Shobana Shankar 7 Jun 2019
Decolonising healthcare
6 Jun 2019
Why Ebola vaccine on trial in the DRC is raising hopes
Shirin Ashraf & Arthur Wickenhagen 11 Feb 2019
Why African countries need to give genomic research a major boost
Lamech Mwapagha 30 Jan 2019
